ESMO Open
Latest Publications

TOTAL DOCUMENTS

984
(FIVE YEARS 326)

H-INDEX

30
(FIVE YEARS 1)

Published By Bmj

2059-7029
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100314
Author(s):  
M.M. Javle ◽  
D.-Y. Oh ◽  
M. Ikeda ◽  
W.-P. Yong ◽  
K. Hsu ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Tract Cancer ◽  
Randomized Phase Ii

scholarly journals IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100353
Author(s):  
O. Molinier ◽  
B. Besse ◽  
F. Barlesi ◽  
C. Audigier-Valette ◽  
S. Friard ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Term Survival ◽  
Long Term Survival ◽  
Real World Evidence

scholarly journals ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100344
Author(s):  
G. Pentheroudakis ◽  
G. Curigliano ◽  
C. Zielinski
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
New Approaches

scholarly journals Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patients

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100366
Author(s):  
T. Samaille ◽  
C. Moreau Bachelard ◽  
E. Coquan ◽  
P. du Rusquec ◽  
X. Paoletti ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Progression Free Survival ◽  
Advanced Cancer Patients ◽  
Free Survival ◽  
Median Progression Free Survival

scholarly journals Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100341
Author(s):  
Y. Cao ◽  
S. Qin ◽  
S. Luo ◽  
Z. Li ◽  
Y. Cheng ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell

scholarly journals Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100357
Author(s):  
M.A. Gouda ◽  
J. Polivka ◽  
H.J. Huang ◽  
I. Treskova ◽  
K. Pivovarcikova ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Circulating Tumor Dna ◽  
Ultrasensitive Detection ◽  
Braf Mutations ◽  
Tumor Dna

scholarly journals Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100336
Author(s):  
M. Palmeri ◽  
J. Mehnert ◽  
A.W. Silk ◽  
S.K. Jabbour ◽  
S. Ganesan ◽  
...  
Keyword(s):  
Microsatellite Instability ◽  
Real World ◽  
Real World Application ◽  
Mutational Burden ◽  
Tumor Mutational Burden
Load More ...
Sign in / Sign up

Export Citation Format

Share Document